European Journal of Cancer
Volume 45, Issue 1 , Pages 74-81 , January 2009

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

  • P.N. Span

      Affiliations

    • Department of Chemical Endocrinology 479, Radboud University Nijmegen Medical Centre, P.O. Box 9101, NL-6500 HB Nijmegen, Nijmegen, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 24 3614279; fax: +31 24 3541484.
  • ,
  • A.M. Sieuwerts

      Affiliations

    • Department of Medical Oncology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands
  • ,
  • J.J.T.M. Heuvel

      Affiliations

    • Department of Chemical Endocrinology 479, Radboud University Nijmegen Medical Centre, P.O. Box 9101, NL-6500 HB Nijmegen, Nijmegen, The Netherlands
  • ,
  • F. Spyratos

      Affiliations

    • Centre René Huguenin, Laboratoire d’Oncogénetique/INSERMU735, St-Cloud, France
  • ,
  • M.J. Duffy

      Affiliations

    • Department of Pathology and Laboratory Medicine, St. Vincent’s University Hospital, Dublin, Ireland
    • UCD School of Medicine and Medical Science, Conway Institute, University College, Dublin, Ireland
  • ,
  • S. Eppenberger-Castori

      Affiliations

    • Stiftung Tumorbank Basel, Riehen, Switzerland
  • ,
  • S. Vacher

      Affiliations

    • Centre René Huguenin, Laboratoire d’Oncogénetique/INSERMU735, St-Cloud, France
  • ,
  • K. O’Brien

      Affiliations

    • Department of Pathology and Laboratory Medicine, St. Vincent’s University Hospital, Dublin, Ireland
    • UCD School of Medicine and Medical Science, Conway Institute, University College, Dublin, Ireland
  • ,
  • E. McKiernan

      Affiliations

    • Department of Pathology and Laboratory Medicine, St. Vincent’s University Hospital, Dublin, Ireland
    • UCD School of Medicine and Medical Science, Conway Institute, University College, Dublin, Ireland
  • ,
  • A. Pierce

      Affiliations

    • Department of Pathology and Laboratory Medicine, St. Vincent’s University Hospital, Dublin, Ireland
    • UCD School of Medicine and Medical Science, Conway Institute, University College, Dublin, Ireland
  • ,
  • V. Vuaroqueaux

      Affiliations

    • Stiftung Tumorbank Basel, Riehen, Switzerland
  • ,
  • J.A. Foekens

      Affiliations

    • Department of Medical Oncology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands
  • ,
  • F.C.G.J. Sweep

      Affiliations

    • Department of Chemical Endocrinology 479, Radboud University Nijmegen Medical Centre, P.O. Box 9101, NL-6500 HB Nijmegen, Nijmegen, The Netherlands
  • ,
  • J.W.M. Martens

      Affiliations

    • Department of Medical Oncology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands

Received 9 July 2008 ,Revised 11 September 2008 ,Accepted 30 September 2008.

  • Image Result

    First EQA round. (A) Intra-laboratory CV for each participant per assay. (B) Inter-laboratory CV of samples that were reverse-transcribed by the participants according to their in-house RT protocol or

    First EQA round. (A) Intra-laboratory CV for each participant per assay. (B) Inter-laboratory CV of samples that were reverse-transcribed by the participants according to their in-house RT protocol or by the central EQA laboratory.

  • Image Result
    Second EQA round: intra-laboratory CV for each participant, either per assay (A) or on average for all assays (B). 1–5 denote the different participants. (C) Inter-laboratory CVs per assay.

    Second EQA round: intra-laboratory CV for each participant, either per assay (A) or on average for all assays (B). 1–5 denote the different participants. (C) Inter-laboratory CVs per assay.

  • Image Result
    Third EQA round: intra-laboratory CV for each participant, either per assay (A) or on average for all assays (B). 1–5 denote the different participants. (C) Inter-laboratory CVs per assay. PITX2A and

    Third EQA round: intra-laboratory CV for each participant, either per assay (A) or on average for all assays (B). 1–5 denote the different participants. (C) Inter-laboratory CVs per assay. PITX2A and B2M values for participant 4 are missing.

  • Image Result
    (A) Harmonisation factors for the different assays and participants. (B) Effect of harmonisation of data on inter-laboratory CV per assay. (C) Effect of normalisation – using reference gene expression

    (A) Harmonisation factors for the different assays and participants. (B) Effect of harmonisation of data on inter-laboratory CV per assay. (C) Effect of normalisation – using reference gene expression – of data on inter-laboratory CV per assay.

PII: S0959-8049(08)00790-9

doi: 10.1016/j.ejca.2008.09.030

European Journal of Cancer
Volume 45, Issue 1 , Pages 74-81 , January 2009